Header Logo

Connection

Julie Schmittdiel to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Julie Schmittdiel has written about Hypoglycemic Agents.
Julie Schmittdiel
Connection Strength
3.900
Hypoglycemic Agents
  1. Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. BMC Health Serv Res. 2019 Jun 25; 19(1):422.
    View in: PubMed
    Score: 0.551
  2. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control. J Manag Care Spec Pharm. 2018 Sep; 24(9):856-861.
    View in: PubMed
    Score: 0.521
  3. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
    View in: PubMed
    Score: 0.411
  4. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2015 Apr; 50(2):537-59.
    View in: PubMed
    Score: 0.393
  5. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug; 54(4):374-82.
    View in: PubMed
    Score: 0.390
  6. Safety and effectiveness of mail order pharmacy use in diabetes. Am J Manag Care. 2013 Nov; 19(11):882-7.
    View in: PubMed
    Score: 0.372
  7. Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment. JAMA Netw Open. 2021 09 01; 4(9):e2126605.
    View in: PubMed
    Score: 0.160
  8. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins. JAMA Netw Open. 2020 01 03; 3(1):e1918554.
    View in: PubMed
    Score: 0.143
  9. Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study. J Manag Care Spec Pharm. 2015 Aug; 21(8):688-98.
    View in: PubMed
    Score: 0.105
  10. Response to comment on O'Connor et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes care 2014;37:3317-3324. Diabetes Care. 2015 Mar; 38(3):e46.
    View in: PubMed
    Score: 0.102
  11. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015 Apr; 38(4):604-9.
    View in: PubMed
    Score: 0.101
  12. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec 01; 20(12):e573-81.
    View in: PubMed
    Score: 0.100
  13. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014 Dec; 37(12):3317-24.
    View in: PubMed
    Score: 0.099
  14. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf. 2014 Jul; 23(7):699-710.
    View in: PubMed
    Score: 0.096
  15. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. Ann Pharmacother. 2013 Oct; 47(10):1280-91.
    View in: PubMed
    Score: 0.093
  16. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010 Jan; 16(1):33-40.
    View in: PubMed
    Score: 0.071
  17. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
    View in: PubMed
    Score: 0.063
  18. Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies. J Comp Eff Res. 2014 Jul; 3(4):359-69.
    View in: PubMed
    Score: 0.024
  19. Targeted learning in real-world comparative effectiveness research with time-varying interventions. Stat Med. 2014 Jun 30; 33(14):2480-520.
    View in: PubMed
    Score: 0.024
  20. A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study. BMC Pregnancy Childbirth. 2014 Jan 15; 14:21.
    View in: PubMed
    Score: 0.024
  21. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012 Jun 12; 125(23):2863-72.
    View in: PubMed
    Score: 0.021
  22. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010 Nov; 25(11):1172-7.
    View in: PubMed
    Score: 0.018
  23. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
    View in: PubMed
    Score: 0.017

© 2024 Kaiser Permanente